Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1292436

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1292436

Sleep Apnea Devices Market by Type, Therapeutic (PAP Facial Interfaces, Oral Appliances, Accessories), Diagnostic, End User & Region - Global Forecast to 2028

PUBLISHED:
PAGES: 290 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

The global sleep apnea devices market is projected to reach USD 8.0 Billion by 2028 from USD 5.8 Billion in 2023, at a CAGR of 6.5% during the forecast period. The growth of this market is majorly driven by the growth in the reimbursment for sleep apnea devices and therapies. However, high cost of CPAP to restrain the growth of sleep apnea devices market.

"The CPAP devices segment accounted for the highest market share in the sleep apnea PAP devices systems market, by type, during the forecast period"

Based on the type segment, the sleep apnea PAP devices system market is categorized into continuous positive airway pressure (CPAP) devices, automatic positive airway pressure (APAP) devices, and bilevel positive airway pressure (BPAP) devices. Continuous positive airway pressure (CPAP) devices deliver continuous and constant positive pressure to open the airways. CPAP devices are gold standard and the most commonly used PAP devices.

"Home sleep testing devices systems accounted for the highest CAGR during the forecast period"

Based on type, the diagnostic sleep apnea devices systens market is segmented into polysomnography devices, home sleep testing devices, oximeters, actigraphy systems, and sleep screening devices. In 2022, the polysomnography devices system dominated the market and home sleep testing devices systems to observe the highest growth rate. Factors supporting the growth of home sleep testing devices are due to its advantage to the homebound, the elderly, or those with chronic illnesses who require specialized care at home.

"The Asia Pacific segment accounted for the highest growth rate in the sleep apnea devices systems market, by region, during the forecast period"

Based on the region, the global sleep apnea devices market is categorized into North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific is expected to witness high growth rate during the forecast period. The massive patient pool and a large population of undiagnosed patients hold massive potential for the Asia Pacific sleep apnea devices market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (55%), Tier 2 (40%), and Tier 3 (5%)
  • By Designation: C-level (37%), Director-level (48%), and Others (15%)
  • By Region: North America (56%), Asia- Pacific (20%), Europe (17%), and Rest of the World (7%)

Prominent companies include ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Oventus Medical (Australia), Compumedics (Australia), Lowenstein Medical Technology GmbH + Co. K.G. (Germany), Drive DeVilbiss Healthcare (US), BMC Medical Co. (China), BRAEBON Medical Corporation (Canada), Whole You, Inc. (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova (UK), Invacare Corporation (US), MPowrx Health & Wellness (Canada), Nihon Kohden (Japan), Natus Medical Incorporated (US), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US).

Research Coverage

This research report categorizes the sleep apnea devices market by product (therapeutic devices and diagnostic devices), by end user (sleep laboratories, clinics & hospitals and home care settings/individuals), and region (North America, Europe, Asia Pacific, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the sleep apnea devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the sleep apnea devices market. Competitive analysis of upcoming startups in the sleep apnea devices market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall sleep apnea devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (large pool of undiagnosed sleep apnea patients, favorable reimbursement and financial aid for sleep apnea devices and therapies, growing awareness of effects of untreated sleep apnea, growing usage of oral appliances, and increasing number of companies venturing into the sleep apnea devices and oral appliances market), restraints (high cost of CPAP machine, complex referral pathways and long waiting periods, alternative therapies and medications), opportunities (growing demand for home sleep apnea tests, increasing focus on telemedicine, mHealth, and AI, emerging markets), and challenges (poor compliance associated with CPAP) influencing the growth of the sleep apnea devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the sleep apnea devices market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the sleep apnea devices market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the sleep apnea devices market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare (New Zealand), among others in the sleep apnea devices market strategies.
Product Code: MD 1181

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • FIGURE 1 SLEEP APNEA DEVICES MARKET SCOPE
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key industry insights
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Breakdown of primary interviews
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.2.1.3 Approach 3: Patient-based approach
    • FIGURE 6 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS
    • 2.2.2 GROWTH FORECAST
    • 2.2.3 CAGR PROJECTIONS
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
    • 2.2.4 TOP-DOWN APPROACH
    • FIGURE 8 SLEEP APNEA DEVICES MARKET: TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 STUDY ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: SLEEP APNEA DEVICES MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 SLEEP APNEA DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 SLEEP APNEA DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 SLEEP APNEA DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 SLEEP APNEA DEVICES MARKET OVERVIEW
    • FIGURE 15 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS GLOBALLY TO DRIVE MARKET
  • 4.2 SLEEP APNEA DEVICES MARKET, BY REGION (2023-2028)
    • FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT AND COUNTRY (2022)
    • FIGURE 17 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SLEEP APNEA DEVICES MARKET IN 2022
  • 4.4 SLEEP APNEA DEVICES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC TO GROW AT HIGHEST RATE DURING STUDY PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 SLEEP APNEA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Large pool of undiagnosed sleep apnea patients globally
    • TABLE 3 PREVALENCE OF SLEEP APNEA IN 2020
      • 5.2.1.2 Favorable reimbursement and financial aid for sleep apnea devices and therapies
    • TABLE 4 REIMBURSEMENT CODES AND COSTS OF MAJOR SLEEP APNEA DEVICES BY RESMED
    • TABLE 5 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL
      • 5.2.1.3 Growing awareness about effects of untreated sleep apnea among patients
    • TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA
      • 5.2.1.4 Growing usage of oral appliances among patients with mild to low-moderate sleep apnea
    • TABLE 7 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA
      • 5.2.1.5 Rising number of companies in sleep apnea devices and oral appliances market
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of CPAP machines and minimal insurance access in developing countries
      • 5.2.2.2 Complex referral pathways, long waiting periods, and delayed diagnosis
      • 5.2.2.3 Alternative therapies and medications for sleep apnea
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for home sleep apnea tests as cost-saving measure
      • 5.2.3.2 Increasing focus on telemedicine, mHealth, and AI
      • 5.2.3.3 Increased interest of sleep apnea device manufacturers toward emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Poor patient compliance associated with CPAP therapy
  • 5.3 PRICING ANALYSIS
    • TABLE 8 AVERAGE SELLING PRICE OF PAP DEVICES
    • TABLE 9 AVERAGE SELLING PRICE OF FACIAL INTERFACES
    • TABLE 10 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL APPLIANCES
    • TABLE 11 COST OF SLEEP APNEA TESTING METHODS
    • TABLE 12 AVERAGE SELLING PRICE OF SLEEP APNEA DEVICES, BY KEY PLAYER
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 21 DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY OF PROMINENT COMPANIES
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 22 SLEEP APNEA DEVICES MARKET: ECOSYSTEM ANALYSIS
    • 5.7.1 ROLE IN ECOSYSTEM
    • FIGURE 23 KEY PLAYERS IN SLEEP APNEA DEVICES MARKET ECOSYSTEM
  • 5.8 REGULATORY ANALYSIS
    • TABLE 13 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING SLEEP APNEA DEVICES
    • 5.8.1 NORTH AMERICA
      • 5.8.1.1 US
    • TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
        • 5.8.1.1.1 Reimbursement scenario in US
      • 5.8.1.2 Canada
    • TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.8.2 EUROPE
    • 5.8.3 ASIA PACIFIC
      • 5.8.3.1 Japan
    • TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.8.3.2 China
    • TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.8.3.3 India
      • 5.8.3.4 Australia
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT TRENDS FOR SLEEP APNEA DEVICES
    • FIGURE 24 PATENT TRENDS FOR SLEEP APNEA DEVICES, JANUARY 2012-DECEMBER 2022
    • 5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 25 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR SLEEP APNEA ORAL APPLIANCE PATENTS, JANUARY 2012-DECEMBER 2022
  • 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.10.1 REVENUE SHIFT AND REVENUE POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS
    • FIGURE 26 REVENUE SHIFT FOR SLEEP APNEA DEVICES
  • 5.11 KEY CONFERENCES AND EVENTS IN 2022-2023
    • TABLE 18 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2022-2023
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES
    • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES (%)
    • 5.13.2 BUYING CRITERIA
    • FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
    • TABLE 20 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
  • 5.14 TRADE ANALYSIS
    • 5.14.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018-2022 (USD MILLION)
    • 5.14.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2018-2022 (USD MILLION)

6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA

  • 6.1 INTRODUCTION
  • 6.2 EPIDEMIOLOGICAL ASSESSMENT
    • FIGURE 29 TOP TEN COUNTRIES WITH HIGHEST OBSTRUCTIVE SLEEP APNEA PATIENTS (BASED ON AMERICAN ACADEMY OF SLEEP MEDICINE, 2012)
  • 6.3 PRESCRIPTION PATTERN ASSESSMENT
  • 6.4 ADHERENCE ASSESSMENT

7 ALTERNATE THERAPIES FOR SLEEP APNEA

  • 7.1 INTRODUCTION
  • 7.2 EXPIRATORY POSITIVE AIRWAY PRESSURE
  • 7.3 HYPOGLOSSAL NERVE STIMULATION
  • 7.4 ORAL PRESSURE THERAPY
  • 7.5 POSITIONAL THERAPY

8 SLEEP APNEA DEVICES MARKET, BY TYPE

  • 8.1 INTRODUCTION
    • TABLE 21 SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 8.2 THERAPEUTIC DEVICES
    • TABLE 22 SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 23 SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.1 PAP DEVICES
    • TABLE 24 PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 25 PAP DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.1.1 CPAP devices
        • 8.2.1.1.1 CPAP devices to provide best standard sleep apnea treatment for patients globally
    • TABLE 26 CPAP DEVICES OFFERED BY KEY PLAYERS
    • TABLE 27 CPAP DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.1.2 APAP devices
        • 8.2.1.2.1 Increasing patient non-compliance with CPAP devices and growing awareness among sleep specialists to boost segment
    • TABLE 28 APAP DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.1.3 BPAP devices
        • 8.2.1.3.1 Increased complexity and cost with high product recalls from major companies to lower adoption
    • TABLE 29 BPAP DEVICES OFFERED BY KEY PLAYERS
    • TABLE 30 BPAP DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.2 FACIAL INTERFACES
    • TABLE 31 FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 32 FACIAL INTERFACES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.2.1 Masks
    • TABLE 33 MASKS OFFERED BY KEY PLAYERS
    • TABLE 34 MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 35 MASKS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • 8.2.2.1.1 Full-face masks
          • 8.2.2.1.1.1 Full-face masks to be most effective for mouth breathers or patients struggling with breathing through nose
    • TABLE 36 FULL-FACE MASKS OFFERED BY KEY PLAYERS
    • TABLE 37 FULL-FACE MASKS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • 8.2.2.1.2 Nasal pillow masks
          • 8.2.2.1.2.1 Greater patient compliance due to smaller size and better fit to drive demand
    • TABLE 38 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS
    • TABLE 39 NASAL PILLOW MASKS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • 8.2.2.1.3 Nasal masks
          • 8.2.2.1.3.1 Nasal masks to minimize obstruction of patients' view and allow patients to wear spectacles
    • TABLE 40 NASAL MASKS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.2.2 Cushions
        • 8.2.2.2.1 Different product varieties and launches by major companies in past few years to drive market
    • TABLE 41 CUSHIONS OFFERED BY KEY PLAYERS
    • TABLE 42 CUSHIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.3 ACCESSORIES
    • TABLE 43 ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 44 ACCESSORIES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.3.1 Humidifier accessories
        • 8.2.3.1.1 Humidifiers to open airways, decrease congestion, and encourage clearer breathing
    • TABLE 45 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.3.2 Power accessories
        • 8.2.3.2.1 Power accessories to manage uninterrupted sleep apnea therapy in absence of power supply
    • TABLE 46 POWER ACCESSORIES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.3.3 Transportation accessories
        • 8.2.3.3.1 Convenience associated with transportation accessories while traveling to drive market
    • TABLE 47 TRANSPORTATION ACCESSORIES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.3.4 Communication accessories
        • 8.2.3.4.1 Communication accessories to monitor sleep apnea symptoms through teleconsultations
    • TABLE 48 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.3.5 Chin restraints
        • 8.2.3.5.1 Chin restraints to hold mouth in position during therapy
    • TABLE 49 CHIN RESTRAINTS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.3.6 Other accessories
    • TABLE 50 OTHER ACCESSORIES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.4 ORAL APPLIANCES
    • TABLE 51 ORAL APPLIANCES OFFERED BY KEY PLAYERS
    • TABLE 52 ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 53 ORAL APPLIANCES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.4.1 Mandibular advancement devices
        • 8.2.4.1.1 Mandibular advancement devices to treat mild obstructive sleep apnea and snoring
    • TABLE 54 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.2.4.2 Tongue-retaining devices
        • 8.2.4.2.1 Tongue-retaining devices to be less expensive and reduce both snoring and sleep apnea
    • TABLE 55 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.5 ADAPTIVE SERVO-VENTILATORS
      • 8.2.5.1 Improved clinical outcomes associated and better ventilation support as per breathing patterns to fuel market
    • TABLE 56 ADAPTIVE SERVO-VENTILATORS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.6 OTHER THERAPEUTIC DEVICES
    • TABLE 57 OTHER THERAPEUTIC DEVICES OFFERED BY KEY PLAYERS
    • TABLE 58 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 DIAGNOSTIC DEVICES
    • TABLE 59 SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 60 SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.1 PSG DEVICES
    • TABLE 61 PSG DEVICES OFFERED BY KEY PLAYERS
    • TABLE 62 PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 PSG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.3.1.1 Ambulatory PSG devices
        • 8.3.1.1.1 Cost-effectiveness and convenience for patients to propel segment
    • TABLE 64 AMBULATORY PSG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.3.1.2 Clinical PSG devices
        • 8.3.1.2.1 Requirement of constant supervision to limit segment growth
    • TABLE 65 CLINICAL PSG DEVICES OFFERED BY KEY PLAYERS
    • TABLE 66 CLINICAL PSG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.2 HOME SLEEP TESTING DEVICES
      • 8.3.2.1 Cost-effectiveness and comfort of home sleep testing to augment segment
    • TABLE 67 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.3 OXIMETERS
    • TABLE 68 OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 OXIMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.3.3.1 Fingertip oximeters
        • 8.3.3.1.1 Lack of precise readings because of injury or slow blood flow due to blood clotting to limit segment
    • TABLE 70 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS
    • TABLE 71 FINGERTIP OXIMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.3.3.2 Handheld oximeters
        • 8.3.3.2.1 Handheld oximeters to be more expensive than fingertips and wrist-worn oximeters
    • TABLE 72 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS
    • TABLE 73 HANDHELD OXIMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.3.3.3 Wrist-worn oximeters
        • 8.3.3.3.1 Small size, long-term usage, and need for overnight monitoring to propel segment
    • TABLE 74 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS
    • TABLE 75 WRIST-WORN OXIMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 8.3.3.4 Tabletop oximeters
        • 8.3.3.4.1 Higher cost and fewer applications for personal use to decrease market share
    • TABLE 76 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS
    • TABLE 77 TABLETOP OXIMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.4 ACTIGRAPHY SYSTEMS
      • 8.3.4.1 Increased focus on assessing actimeter performance to enhance market
    • TABLE 78 ACTIGRAPHY MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.5 SLEEP SCREENING DEVICES
      • 8.3.5.1 Increasing preference for home-based testing for its efficacy and comfort to drive market
    • TABLE 79 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS
    • TABLE 80 SLEEP SCREENING DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

9 SLEEP APNEA DEVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 81 SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 SLEEP LABORATORIES, CLINICS, AND HOSPITALS
    • 9.2.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
    • TABLE 82 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES, CLINICS, AND HOSPITALS, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 HOME CARE SETTINGS/INDIVIDUALS
    • 9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET
    • TABLE 83 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2021-2028 (USD MILLION)

10 SLEEP APNEA DEVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 84 SLEEP APNEA DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
    • FIGURE 30 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT
    • TABLE 85 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 87 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 88 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 89 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 NORTH AMERICA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 92 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 94 NORTH AMERICA: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 96 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 US
      • 10.2.2.1 Rising availability of grants and funds and increasing trend of home sleep testing to drive market
    • TABLE 97 KEY SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS IN US
    • TABLE 98 US: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 US: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 100 US: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 101 US: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 US: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 US: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 US: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 105 US: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 106 US: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 107 US: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 108 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Increasing number of research grants and health programs to propel market
    • TABLE 109 KEY SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS IN CANADA
    • TABLE 110 CANADA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 CANADA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 112 CANADA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 CANADA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 115 CANADA: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 116 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 117 CANADA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 118 CANADA: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 CANADA: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3 EUROPE
    • 10.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION
    • TABLE 121 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 122 EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 123 EUROPE: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 124 EUROPE: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 EUROPE: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 127 EUROPE: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 128 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 129 EUROPE: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 130 EUROPE: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 EUROPE: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 High prevalence of obstructive sleep apnea primarily due to smoking to fuel market
    • TABLE 133 KEY SLEEP APNEA PRODUCTS BY MAJOR PLAYERS IN GERMANY
    • TABLE 134 GERMANY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 GERMANY: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 136 GERMANY: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 137 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 138 GERMANY: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 139 GERMANY: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 141 GERMANY: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 142 GERMANY: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 GERMANY: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 144 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Rising geriatric population to increase incidence of sleep apnea
    • TABLE 145 FRANCE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 FRANCE: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 147 FRANCE: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 FRANCE: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 150 FRANCE: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 151 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 FRANCE: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 153 FRANCE: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 FRANCE: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 UK
      • 10.3.4.1 Rising awareness among patients and increasing number of sleep service groups to support market
    • TABLE 156 UK: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 157 UK: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 158 UK: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 159 UK: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 UK: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 UK: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 UK: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 163 UK: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 164 UK: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 165 UK: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Growing prevalence of sleep apnea and increasing awareness among patients regarding ill effects of disease to aid market
    • TABLE 167 ITALY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 168 ITALY: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 169 ITALY: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 170 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 171 ITALY: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 172 ITALY: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 173 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 174 ITALY: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 175 ITALY: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 ITALY: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 177 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Increasing initiatives for social awareness regarding illness and treatment by regional organizations to drive market
    • TABLE 178 SPAIN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 179 SPAIN: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 180 SPAIN: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 181 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 SPAIN: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 183 SPAIN: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 184 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 185 SPAIN: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 186 SPAIN: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 SPAIN: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 188 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 189 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 190 REST OF EUROPE: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 191 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 REST OF EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 193 REST OF EUROPE: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 194 REST OF EUROPE: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 195 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 196 REST OF EUROPE: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 197 REST OF EUROPE: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 REST OF EUROPE: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 199 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
    • FIGURE 31 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT
    • TABLE 200 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 201 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 202 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 203 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 204 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 205 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 206 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 207 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 208 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Changing reimbursement scenario and increasing demand for cloud-connected sleep apnea therapeutic devices to aid market
    • TABLE 212 JAPAN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 213 JAPAN: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 214 JAPAN: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 215 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 216 JAPAN: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 217 JAPAN: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 218 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 219 JAPAN: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 220 JAPAN: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 221 JAPAN: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 222 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 CHINA
      • 10.4.3.1 Growing adult obesity rates and expanding geriatric population to propel market
    • TABLE 223 CHINA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 224 CHINA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 225 CHINA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 226 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 227 CHINA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 228 CHINA: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 229 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 230 CHINA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 231 CHINA: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 232 CHINA: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 233 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 High prevalence of sleep apnea and increased number of awareness programs to drive market
    • TABLE 234 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 235 AUSTRALIA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 236 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 237 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 238 AUSTRALIA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 239 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 240 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 241 AUSTRALIA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 242 AUSTRALIA: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 243 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 244 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 245 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 246 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 247 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 248 REST OF ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 249 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 250 REST OF ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 251 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 252 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 253 REST OF ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 254 REST OF ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 255 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 256 REST OF THE WORLD: SLEEP APNEA DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 257 REST OF THE WORLD: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 258 REST OF THE WORLD: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 259 REST OF THE WORLD: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 260 REST OF THE WORLD: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 261 REST OF THE WORLD: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 262 REST OF THE WORLD: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 263 REST OF THE WORLD: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 264 REST OF THE WORLD: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 265 REST OF THE WORLD: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 266 REST OF THE WORLD: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 267 REST OF THE WORLD: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Increasing obesity rate to augment prevalence of sleep apnea
      • 10.5.1.2 Latin America: Impact of economic recession
    • TABLE 268 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 269 LATIN AMERICA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 270 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 271 LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 272 LATIN AMERICA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 273 LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 274 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 275 LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 276 LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 277 LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 278 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Dearth of awareness about sleep apnea among general population to limit market
      • 10.5.2.2 Middle East & Africa: Impact of economic recession
    • TABLE 279 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 280 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR THERAPEUTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 281 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 282 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 283 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 284 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 285 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 286 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 287 MIDDLE EAST & AFRICA: PSG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 288 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 289 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN SLEEP APNEA DEVICES MARKET
    • TABLE 290 OVERVIEW OF STRATEGIES ADOPTED BY KEY SLEEP APNEA DEVICE MANUFACTURERS
  • 11.3 REVENUE ANALYSIS
    • FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS
  • 11.4 MARKET SHARE ANALYSIS
    • TABLE 291 SLEEP APNEA DEVICES MARKET: DEGREE OF COMPETITION
    • FIGURE 33 MARKET SHARE ANALYSIS, 2022
  • 11.5 COMPANY EVALUATION MATRIX
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 34 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION QUADRANT
  • 11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 35 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
  • 11.7 COMPANY FOOTPRINT ANALYSIS
    • TABLE 292 COMPANY FOOTPRINT OF PLAYERS IN SLEEP APNEA DEVICES MARKET
    • TABLE 293 COMPANY PRODUCT FOOTPRINT
    • TABLE 294 COMPANY REGIONAL FOOTPRINT
  • 11.8 COMPETITIVE BENCHMARKING
    • TABLE 295 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 KEY PRODUCT LAUNCHES AND APPROVALS
    • TABLE 296 SLEEP APNEA DEVICES MARKET: KEY PRODUCT LAUNCHES AND APPROVALS, 2020-2023
    • 11.9.2 KEY DEALS
    • TABLE 297 SLEEP APNEA DEVICES MARKET: KEY DEALS, 2020-2023
    • 11.9.3 OTHER KEY DEVELOPMENTS
    • TABLE 298 SLEEP APNEA DEVICES MARKET: OTHER KEY DEVELOPMENTS, 2020-2023

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 RESMED
    • TABLE 299 RESMED: COMPANY OVERVIEW
    • FIGURE 36 RESMED: COMPANY SNAPSHOT (2022)
    • 12.1.2 KONINKLIJKE PHILIPS N.V.
    • TABLE 300 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 12.1.3 FISHER & PAYKEL HEALTHCARE LIMITED
    • TABLE 301 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
    • FIGURE 38 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2022)
    • 12.1.4 INSPIRE MEDICAL SYSTEMS, INC.
    • TABLE 302 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
    • FIGURE 39 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.5 SOMNOMED
    • TABLE 303 SOMNOMED: COMPANY OVERVIEW
    • FIGURE 40 SOMNOMED: COMPANY SNAPSHOT (2022)
    • 12.1.6 OVENTUS MEDICAL
    • TABLE 304 OVENTUS MEDICAL: COMPANY OVERVIEW
    • FIGURE 41 OVENTUS MEDICAL: COMPANY SNAPSHOT (2022)
    • 12.1.7 COMPUMEDICS LIMITED
    • TABLE 305 COMPUMEDICS LIMITED: COMPANY OVERVIEW
    • FIGURE 42 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2022)
    • 12.1.8 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.
    • TABLE 306 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: COMPANY OVERVIEW
    • 12.1.9 DRIVE DEVILBISS HEALTHCARE
    • TABLE 307 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW
    • 12.1.10 BMC MEDICAL CO., LTD.
    • TABLE 308 BMC MEDICAL CO., LTD.: COMPANY OVERVIEW
    • 12.1.11 BRAEBON MEDICAL CORPORATION
    • TABLE 309 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW
    • 12.1.12 WHOLE YOU, INC.
    • TABLE 310 WHOLE YOU, INC.: COMPANY OVERVIEW
    • 12.1.13 PANTHERA DENTAL
    • TABLE 311 PANTHERA DENTAL: COMPANY OVERVIEW
    • 12.1.14 MYERSON LLC
    • TABLE 312 MYERSON LLC: COMPANY OVERVIEW
    • 12.1.15 PROSOMNUS SLEEP TECHNOLOGIES
    • TABLE 313 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW
    • FIGURE 43 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2022)
  • 12.2 OTHER PLAYERS
    • 12.2.1 NIDEK MEDICAL INDIA
    • 12.2.2 TOMED GMBH
    • 12.2.3 LIVANOVA
    • 12.2.4 INVACARE CORPORATION
    • 12.2.5 MPOWRX HEALTH & WELLNESS
    • 12.2.6 NIHON KOHDEN
    • 12.2.7 NATUS MEDICAL INCORPORATED
    • 12.2.8 VIVOS THERAPEUTICS
    • 12.2.9 AIRWAY MANAGEMENT
    • 12.2.10 APNEA SCIENCES
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!